Patients Subjected To CNS-Radiotherapy In Childhood Prone To Radiation-Induced Meningiomas Later
- byDoctor News Daily Team
- 05 August, 2025
- 0 Comments
- 0 Mins
Patients who underwent CNS-radiotherapy in childhood for any condition have an increased risk of developing secondary brain tumors such as radiation-induced meningiomas (RIMs), shows a recent study published in Brain and Spine journal.
Meningiomas are the most common primary brain tumors in adults and represent almost one-third of all primary tumors of the central neural system (CNS). Various risk factors have been blamed for their development, like ionizing radiation (therapeutic, diagnostic, or random exposure), hormonal factors, and genetic predilection syndromes.
Indeed, the effects of ionizing radiation on intracranial meningioma growth were first studied by Munk in 1969, and since then, many researchers have linked radiation exposure with the development of different types of cerebral tumors. One of the main causing factors of meningiomas is radiation, hence the amount of radiation and the site of it play a significant role in the side-effects of it, like the formation of meningiomas
In the international bibliography, meningiomas occurring within a previously radiated field after a defined latency period are being called “Radiation-Induced Meningiomas (RIM)”
For a tumor to be considered Radiation-Induced Meningioma, it should be formed within the irradiated field, appear with different histological characteristics from other previous tumors,
at least five years should have elapsed between irradiation and meningioma’s appearance, it should have been absent during irradiation, patient should not have a metastatic tumor, and
the incidence of neurofibromatosis type II should be excluded.
A retrospective study was undertaken by Banos et al to investigate the association of CNS irradiation during childhood with the development of meningioma in adult patients, managed at the Department of Neurosurgery of ‘Attikon’ General University Hospital, from January 2012 to September 2022.l, in which they examined the cases of thirteen patients with radiation-induced meningioma (RIM) who were diagnosed and treated in the neurosurgical department. These patients had been irradiated during their childhood for paediatric cancer.
Their study concluded that patients who underwent CNS radiation therapy in childhood for any condition had an increased risk of developing in adulthood secondary brain tumors -benign or malignant-such as radiation-induced meningiomas. The RIMs resembled sporadic meningiomas in symptomatology, location, treatment, and histological grade. They also advice that long-term follow-up and regular check-ups are recommended in irradiated patients due to the short latency period from irradiation to RIM development, as these patients are younger than those with sporadic meningiomas cases. Further research is needed to identify the regular manner in which follow-up should be suggested in such patients.
Reference
Stamatios Banos a, Mary Solou a, Ioannis Ydreos a, Evangelos K. Papadopoulos a, Georgios Savvanis a, Anastasios A. Politis a, Lampis C. Stavrinou a, Maria M. Gavra b, Efstathios J. Boviatsis a
Brain and Spine
Volume 3, 2023, 101719
https://doi.org/10.1016/j.bas.2023.101719
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
Health Ministry Proposes Barcoding Rule for All Va...
- 23 October, 2025
Boehringer Ingelheim Jascayd gets nod in China for...
- 23 October, 2025
Mizoram reports 121 multidrug-resistant TB Deaths...
- 23 October, 2025
GSK Shingrix new prefilled syringe presentation ge...
- 23 October, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!